Molecular Characterization of TET2 in Cytogenetically Normal Acute Myeloid Leukemia

被引：0
|
作者：
Lee, J. [1 ,2 ]
Jun, K. [2 ]
Song, S. [2 ]
Oh, S. [1 ]
Shin, J. [1 ]
Kim, H. [1 ]
Lee, J. [1 ,2 ]
机构：
[1] Inje Univ, Busan Paik Hosp, Pusan, South Korea
[2] Haeundae Paik Hosp, Pusan, South Korea
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2013年 / 15卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：858 / 858
页数：1
相关论文
共 50 条
  • [31] Impact of molecular prognostic factors in cytogenetically normal acute myeloid leukemia at diagnosis and relapse
    Walker, Alison
    Marcucci, Guido
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (05): : 640 - 643
  • [32] Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia
    Yamazaki, Jumpei
    Taby, Rodolphe
    Jelinek, Jaroslav
    Raynal, Noel J. M.
    Cesaroni, Matteo
    Pierce, Sherry A.
    Kornblau, Steven M.
    Bueso-Ramos, Carlos E.
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Issa, Jean-Pierre J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (02):
  • [33] Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype
    Ahn, Jae-Sook
    Kim, Hyeoung-Joon
    Kim, Yeo-Kyeoung
    Jung, Sung-Hoon
    Yang, Deok-Hwan
    Lee, Je-Jung
    Lee, Il-Kwon
    Kim, Nan Young
    Minden, Mark D.
    Jung, Chul Won
    Jang, Jun-Ho
    Kim, Hee Je
    Moon, Joon Ho
    Sohn, Sang Kyun
    Won, Jong-Ho
    Kim, Sung-Hyun
    Kim, Namshin
    Yoshida, Kenichi
    Ogawa, Seishi
    Kim, Dennis Dong Hwan
    HAEMATOLOGICA, 2015, 100 (09) : E351 - E353
  • [34] Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
    Schlenk, Richard F.
    Doehner, Konstanze
    Krauter, Juergen
    Froehling, Stefan
    Corbacioglu, Andrea
    Bullinger, Lars
    Habdank, Marianne
    Spaeth, Daniela
    Morgan, Michael
    Benner, Axel
    Schlegelberger, Brigitte
    Heil, Gerhard
    Ganser, Arnold
    Doehner, Hartmut
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (18): : 1909 - 1918
  • [35] Immunological markers for prognostication in cytogenetically normal acute myeloid leukemia
    Ling, Victoria Y.
    Lee, Denise
    Mcquilten, Zoe
    Avery, Sharon
    Low, Michael
    Cody, Stephen H.
    Trung Nguyen
    Mclean, Catriona
    Gorniak, Malgorzata
    Wei, Andrew
    Ting, Stephen B.
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (12) : E219 - E220
  • [36] Mutations In the Tet Oncogene Family Member 2 (TET2) Gene Refine the New European LeukemiaNet Risk Classification of Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) In Adults: A Cancer and Leukemia Group B (CALGB) Study
    Metzeler, Klaus H.
    Maharry, Kati
    Radmacher, Michael D.
    Mrozek, Krzysztof
    Margeson, Dean
    Becker, Heiko
    Curfman, John
    Holland, Kelsi B.
    Schwind, Sebastian
    Whitman, Susan P.
    Wu, Yue-Zhong
    Blum, William
    Powell, Bayard L.
    Carter, Thomas H.
    Wetzler, Meir
    Moore, Joseph O.
    Kolitz, Jonathan E.
    Baer, Maria R.
    Carroll, Andrew J.
    Larson, Richard A.
    Caligiuri, Michael A.
    Marcucci, Guido
    Bloomfield, Clara D.
    BLOOD, 2010, 116 (21) : 48 - 49
  • [37] Prevalence & Prognosis Value of TET2 Gene Polymorphisms in Childhood Acute Myeloid Leukemia in Taiwan
    Li, Meng-Ju
    Yang, Yung-Li
    Jou, Shiann-Tarng
    Lu, Meng-Yao
    Chang, Hsiu-Hao
    Lin, Kai-Hsin
    Lin, Dong-Tsamn
    Peng, Ching-Tien
    BLOOD, 2011, 118 (21) : 674 - 674
  • [38] TET2, ANPM1 and FLT3-ITD Gene Mutations in Normal Karyotype Acute Myeloid Leukemia
    Sun, Aining
    Tian, Xiaopeng
    Yin, Jia
    Li, Weiyang
    Chen, Suning
    Wu Depei
    BLOOD, 2012, 120 (21)
  • [39] The prognostic role of C-KIT, TET1 and TET2 gene expression in Acute Myeloid Leukemia
    Reem Nabil
    Naglaa M. Hassan
    Mona S. Abdellateif
    Rania M. Gawdat
    Samar Sami Elshazly
    Molecular Biology Reports, 2023, 50 : 641 - 653
  • [40] DOUBLE INACTIVATION OF TET2 AND TET3 INDUCES HYPOMETHYLATING AGENT-SENSITIVE ACUTE MYELOID LEUKEMIA
    Maie, K.
    Sakata-Yanagimoto, M.
    Oshima, M.
    Kato, T.
    Muto, H.
    Mouly, E.
    Bernard, O. A.
    Koseki, H.
    Iwama, A.
    Chiba, S.
    HAEMATOLOGICA, 2016, 101 : 212 - 212
12345